Please login to the form below

Not currently logged in
Email:
Password:

Takeda mulls bid for Irish biopharma Shire

The Japanese pharma firm must make a formal offer by 25 April

Takeda

Takeda, Japan’s largest pharmaceutical company by sales, has announced that it’s considering a possible takeover deal for Shire, a biopharma focused on rare diseases.

The news sparked a 25% surge in Shire’s shares during yesterday morning’s trading however according to Takeda, the consideration of such an offer is at a ‘preliminary’ and exploratory’ stage, with no actual approach made to the board of Shire.

In a press release announced earlier today, Takeda said a “potential transaction with Shire presents an opportunity to strengthen the company’s core therapeutic areas of oncology, gastrointestinal and neuroscience”.

It also added that the deal could build on Takeda’s “current strong momentum”, and could create a “truly global, value-based Japanese biopharmaceutical leader”.

Takeda, which has until 25 April to make a formal offer, isn’t the only company that has seen potential with Shire, as it was recently tipped as the next big pharma takeover after AbbVie’s failed takeover bid in 2014.

That particular deal, which saw AbbVie offer $55bn for the biopharma, came to a halt after the US introduced new measures to discourage tax inversion deals.

Article by
Gemma Jones

29th March 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
How scientific storytelling can help Pharma cut through the noise
Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...